Pharmacopeia
ERYTHROMYCIN
Core pharmacology
- Introduction
Macrolide antibiotic
- Absorption
10-60% absorption
Undergoes first pass metabolism- Distribution
Poor CSF penetration but good lung penetration
- Protein binding
85% PB
- Volume of distribution
Vd 0.3-1.2L/kg
- Metabolism
Hepatic demethylation
- Excretion
Renally excreted (15% unchanged)
- Half-life
T1/2= 1.5 hours
- Class Group
ANTIBIOTIC:
MACROLIDE- Presentation
Topical, oral, IV
- Antimicrobial Spectrum
1. Gram positives
2. Anaerobes
Obligate intracellular organisms (legionella, mycoplasma)- Mechanism of action
Macrolide antimicrobial that binds the 50S ribosomal subunit and inhibits bacterial protein synthesis. It also acts as a motilin-receptor agonist in the stomach and duodenum, increasing lower-oesophageal sphincter tone and gastrointestinal motility.
- Adverse Effects Toxicity
1. Must be avoided in porphyria 2. Nausea, vomiting, diarrhea 3. Hypersensitivity 4. QT prolongation and increased risk of torsade’s 5. Inhibits CYP3A4 (increased warfarin, carbamazepine, ciclosporin, valproate, tacrolimus, digoxin) Inhibits p-glycoprotein